Inogen Stock Earnings Reports
INGN Upcoming Earnings (Q3 2023)
Earnings Date: | Oct 31, 2023 |
Consensus EPS: | Premium |
Current P/E* ratio: -81.61 | Price (Sep 20, 2023, EOD): $5.20
*The P/E ratio (price-to-earnings ratio) is a financial metric used to assess a company's stock valuation. It is calculated by dividing the stock price by its earnings per share. A higher ratio suggests higher investor expectations, while a lower ratio may indicate undervaluation. It helps investors evaluate potential investments, but it's essential to consider other factors too.
Last 3 Quarters for INGN Premium
FAQ
About Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the pa... INGN Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.